Brands: Vidaza · Azacitidine
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Dr.Reddy's laboratories Limited | unknown | 4 | SUPPLYING |
| BluePoint Laboratories | unknown | 3 | SUPPLYING |
| Meitheal Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 1 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 1 | SUPPLYING |
| Sandoz Inc | unknown | 1 | SUPPLYING |
| MSN Laboratories Private Limited | unknown | 1 | SUPPLYING |
| Accord Healthcare Inc. | unknown | 1 | SUPPLYING |
| Armas Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| Eugia US LLC | unknown | 1 | SUPPLYING |
| Reliance Life Sciences Private Limited | unknown | 1 | SUPPLYING |
| Celgene Corporation | unknown | 1 | SUPPLYING |
| Apotex Corp. | unknown | 1 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
| Somerset Therapeutics, LLC | unknown | 1 | SUPPLYING |
+ 3 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification. — Recalling firm: Teva Pharmaceuticals USA Inc — Distributed in Ohio
Failed stability specifications — Recalling firm: Dr. Reddy's Laboratories, Inc. — USA Nationwide
Failed stability specifications — Recalling firm: Dr. Reddy's Laboratories, Inc. — USA Nationwide
Azacitidine Injection — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Oncology.
Azacitidine Injection — reported in shortage by Eugia US LLC. Therapeutic category: Oncology.
Azacitidine Injection — reported in shortage by Accord Healthcare Inc.. Therapeutic category: Oncology.
Azacitidine Injection — reported in shortage by Meitheal Pharmaceuticals, Inc.. Therapeutic category: Oncology.
Azacitidine Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Oncology.
Azacitidine Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Oncology.
Azacitidine Injection — reported in shortage by Bristol Myers Squibb Co.. Therapeutic category: Oncology.
Azacitidine Injection — reported in shortage by Dr. Reddy's Laboratories, Inc.. Therapeutic category: Oncology.
Azacitidine Injection — reported in shortage by Armas Pharmaceuticals Inc. Therapeutic category: Oncology.
CGMP Deviations — Recalling firm: Shilpa Medicare Limited — Nationwide in the U.S.
Pill